Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

BioGaia AB (publ)

BIOGYPNK
Healthcare
Drug Manufacturers - Specialty & Generic
$11.00
$0.00(0.00%)
U.S. Market opens in NaNh NaNm

BioGaia AB (publ) (BIOGY) Stock Overview

Explore BioGaia AB (publ)’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap1.1B
P/E Ratio30.35
EPS (TTM)$0.35
ROE0.24%
Fundamental Analysis

AI Price Forecasts

1 Month$12.38
3 Months$11.07
1 Year Target$9.72

BIOGY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of BioGaia AB (publ) (BIOGY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 53.92, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $9.72.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 30.35 and a market capitalization of 1.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-11.00%
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
6.28%
6-Month Change
15.79%
Year-to-Date (YTD) Change
N/A
1-Year Change
17.65%
3-Year Change
11.68%
5-Year Change
2.14%
All-Time (Max) Change
69.23%

Contact Information

46 8 55 52 93 00
Kungsbroplan 3, Stockholm, NaN, 112 27

Company Facts

2,240 Employees
IPO DateJan 8, 2021
CountrySE
Actively Trading

Frequently Asked Questions